102 related articles for article (PubMed ID: 11860274)
21. Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease.
Koistinen H; Prinjha R; Soden P; Harper A; Banner SJ; Pradat PF; Loeffler JP; Dingwall C
Muscle Nerve; 2006 Oct; 34(4):444-50. PubMed ID: 16856153
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis.
Dupuis L; di Scala F; Rene F; de Tapia M; Oudart H; Pradat PF; Meininger V; Loeffler JP
FASEB J; 2003 Nov; 17(14):2091-3. PubMed ID: 14500553
[TBL] [Abstract][Full Text] [Related]
23. Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD(G93A) mice co-expressing the Copper-Chaperone-for-SOD.
Williams JR; Trias E; Beilby PR; Lopez NI; Labut EM; Bradford CS; Roberts BR; McAllum EJ; Crouch PJ; Rhoads TW; Pereira C; Son M; Elliott JL; Franco MC; Estévez AG; Barbeito L; Beckman JS
Neurobiol Dis; 2016 May; 89():1-9. PubMed ID: 26826269
[TBL] [Abstract][Full Text] [Related]
24. Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1.
Kraft AD; Resch JM; Johnson DA; Johnson JA
Exp Neurol; 2007 Sep; 207(1):107-17. PubMed ID: 17631292
[TBL] [Abstract][Full Text] [Related]
25. Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis.
Watanabe-Matsumoto S; Moriwaki Y; Okuda T; Ohara S; Yamanaka K; Abe Y; Yasui M; Misawa H
Neurosci Res; 2018 Aug; 133():48-57. PubMed ID: 29154923
[TBL] [Abstract][Full Text] [Related]
26. A second ALS patient having an L67P mutation in exon 3 of the Cu/Zn superoxide dismutase gene.
Krieger C; Haase S; Scott P
Amyotroph Lateral Scler; 2011 Nov; 12(6):466-7. PubMed ID: 21692663
[No Abstract] [Full Text] [Related]
27. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis.
Bruening W; Roy J; Giasson B; Figlewicz DA; Mushynski WE; Durham HD
J Neurochem; 1999 Feb; 72(2):693-9. PubMed ID: 9930742
[TBL] [Abstract][Full Text] [Related]
28. Transgenic mice overexpressing the human Cu/Zn-SOD gene: ultrastructural studies of a premature thymic involution model of Down's syndrome (trisomy 21).
Nabarra B; Casanova M; Paris D; Nicole A; Toyama K; Sinet PM; Ceballos I; London J
Lab Invest; 1996 Mar; 74(3):617-26. PubMed ID: 8600312
[TBL] [Abstract][Full Text] [Related]
29. Prion protein expression and superoxide dismutase activity.
Brown DR; Besinger A
Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):423-9. PubMed ID: 9716501
[TBL] [Abstract][Full Text] [Related]
30. Transgenic animal models of familial amyotrophic lateral sclerosis.
Gurney ME
J Neurol; 1997 May; 244 Suppl 2():S15-20. PubMed ID: 9178166
[TBL] [Abstract][Full Text] [Related]
31. Marked reduction of the Cu/Zn superoxide dismutase polypeptide in a case of familial amyotrophic lateral sclerosis with the homozygous mutation.
Kato M; Aoki M; Ohta M; Nagai M; Ishizaki F; Nakamura S; Itoyama Y
Neurosci Lett; 2001 Oct; 312(3):165-8. PubMed ID: 11602336
[TBL] [Abstract][Full Text] [Related]
32. Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis.
Park KH; Vincent I
Biochim Biophys Acta; 2008; 1782(7-8):462-8. PubMed ID: 18485920
[TBL] [Abstract][Full Text] [Related]
33. The roles of free radicals in amyotrophic lateral sclerosis.
Liu D
J Mol Neurosci; 1996; 7(3):159-67. PubMed ID: 8906612
[TBL] [Abstract][Full Text] [Related]
34. Increase of disease duration of amyotrophic lateral sclerosis in a mouse model by transgenic small interfering RNA.
Yokota T; Sasaguri H; Saito Y; Yamada H; Unno T; Yamamoto Y; Kubodera T; Anzai M; Mitani T; Mizusawa H
Arch Neurol; 2007 Jan; 64(1):145-6. PubMed ID: 17210827
[No Abstract] [Full Text] [Related]
35. Impaired retrograde axonal transport of adenovirus-mediated E. coli LacZ gene in the mice carrying mutant SOD1 gene.
Murakami T; Nagano I; Hayashi T; Manabe Y; Shoji M; Setoguchi Y; Abe K
Neurosci Lett; 2001 Aug; 308(3):149-52. PubMed ID: 11479010
[TBL] [Abstract][Full Text] [Related]
36. No superoxide dismutase activity of cellular prion protein in vivo.
Hutter G; Heppner FL; Aguzzi A
Biol Chem; 2003 Sep; 384(9):1279-85. PubMed ID: 14515989
[TBL] [Abstract][Full Text] [Related]
37. Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3.
Moloney C; Rayaprolu S; Howard J; Fromholt S; Brown H; Collins M; Cabrera M; Duffy C; Siemienski Z; Miller D; Borchelt DR; Lewis J
Acta Neuropathol Commun; 2018 Dec; 6(1):137. PubMed ID: 30563574
[TBL] [Abstract][Full Text] [Related]
38. Prion protein expression in muscle cells and toxicity of a prion protein fragment.
Brown DR; Schmidt B; Groschup MH; Kretzschmar HA
Eur J Cell Biol; 1998 Jan; 75(1):29-37. PubMed ID: 9523152
[TBL] [Abstract][Full Text] [Related]
39. Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice.
Leclerc N; Ribera F; Zoll J; Warter JM; Poindron P; Lampert E; Borg J
Neuromuscul Disord; 2001 Nov; 11(8):722-7. PubMed ID: 11595514
[TBL] [Abstract][Full Text] [Related]
40. Early activation of antioxidant mechanisms in muscle of mutant Cu/Zn-superoxide dismutase-linked amyotrophic lateral sclerosis mice.
Jokic N; Di Scala F; Dupuis L; Rene F; Muller A; Gonzalez De Aguilar JL; Loeffler JP
Ann N Y Acad Sci; 2003 Dec; 1010():552-6. PubMed ID: 15033789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
